245 related articles for article (PubMed ID: 35768809)
1. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
[TBL] [Abstract][Full Text] [Related]
2. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
4. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
5. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract][Full Text] [Related]
7. Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors.
Zheng Z; Chen C; Li B; Liu H; Zhou L; Zhang H; Zheng C; He X; Liu W; Hong T; Zhao Y
Front Oncol; 2019; 9():38. PubMed ID: 30805307
[TBL] [Abstract][Full Text] [Related]
8. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine neoplasm of the gallbladder: Clinical features, surgical efficacy, and prognosis.
Wu X; Li B; Hong T; Liu W; He X; Zheng C
Cancer Med; 2023 May; 12(10):11344-11350. PubMed ID: 36952352
[TBL] [Abstract][Full Text] [Related]
10. Precancerous lesions of the biliary tree.
Klöppel G; Adsay V; Konukiewitz B; Kleeff J; Schlitter AM; Esposito I
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):285-97. PubMed ID: 23809246
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
12. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma?
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Kobayashi H; Sueda T
World J Surg; 2011 May; 35(5):1085-93. PubMed ID: 21400012
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of extrahepatic bile duct resection for T2 gallbladder cancer using data from the Japanese Biliary Tract Cancer Registry between 2014 and 2018.
Kato H; Horiguchi A; Ishihara S; Nakamura M; Endo I
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1316-1323. PubMed ID: 37792631
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and survival for gallbladder NEN: a population-based study.
Cen D; Liu H; Wan Z; Lin Z; Wang Y; Xu J; Liang Y
Endocr Connect; 2019 Sep; 8(9):1273-1281. PubMed ID: 31398710
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study.
Lee KJ; Cho JH; Lee SH; Lee KH; Park BK; Lee JK; Woo SM; Ryu JK; Lee JK; Kim YS; Kim JW; Lee WJ
Scand J Gastroenterol; 2017 Apr; 52(4):437-441. PubMed ID: 27924650
[TBL] [Abstract][Full Text] [Related]
17. Synchronous primary tumors of the extrahepatic bile duct and gallbladder.
Kurosaki I; Watanabe H; Tsukada K; Hatakeyama K
J Surg Oncol; 1997 Aug; 65(4):258-62. PubMed ID: 9274790
[TBL] [Abstract][Full Text] [Related]
18. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer.
Lim CS; Jang JY; Lee SE; Kang MJ; Kim SW
J Gastrointest Surg; 2012 May; 16(5):1012-8. PubMed ID: 22271243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
